Huapont Life Sciences Co., Ltd.
Símbolo: 002004.SZ
SHZ
4.42
CNYPrecio de mercado actual
32.7334
Ratio PER
0.7053
Ratio PEG
8.58B
Capitalización MRK
- 0.05%
Rendimiento DIV
Huapont Life Sciences Co., Ltd. (002004-SZ) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 18416.54 | 4413.1 | 4892.9 | 5416.6 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 2174.44 | 630.3 | 706.3 | 1030.4 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 12013.25 | 2844.7 | 3059.7 | 3587.9 | |||||||||||||||||||||||
balance-sheet.row.inventory | 10688.67 | 2674.6 | 2535.6 | 2402.3 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 5150.15 | 1454.9 | 1066 | 907.2 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 46268.61 | 11387.4 | 11554.2 | 12314.1 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 38610.88 | 10024.5 | 8917.6 | 8052.8 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 11376.06 | 2739.9 | 2948.1 | 3439.9 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 6781.25 | 1652.4 | 1759.3 | 1731 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 18157.31 | 4392.4 | 4707.4 | 5170.9 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 9562.98 | 2253.5 | 2234 | 1503.3 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 1649.71 | 434 | 337.1 | 266.2 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 8760.43 | 2235.6 | 2274.1 | 2737.1 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 76741.32 | 19340 | 18470.2 | 17730.4 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 123009.93 | 30727.4 | 30024.4 | 30044.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 9675.35 | 2702.9 | 2374.8 | 2439.3 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 24167.28 | 5693.8 | 6264 | 6294.5 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 916.31 | 177 | 313.2 | 226.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 10912.67 | 2932.1 | 1783.7 | 2273.2 | |||||||||||||||||||||||
Deferred Revenue Non Current | 1144.41 | 271.2 | 278.2 | 258.1 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 430.25 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 149.59 | 29.7 | 2134.1 | 469 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 13263.79 | 3508.9 | 2362 | 2831.4 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 189.03 | 47.6 | 41.9 | 51.6 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 56250.38 | 14142.7 | 13473.6 | 14220.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 84.95 | 84.9 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 7919.68 | 1979.9 | 1979.9 | 1979.9 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9945.12 | 2336.8 | 2544.8 | 2646.9 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 12339.24 | -84.9 | 890.3 | 719.2 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 10549.87 | 5873.4 | 4777 | 4763.4 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 40838.85 | 10105.2 | 10192 | 10109.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 123009.93 | 30727.4 | 30024.4 | 30044.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 25920.71 | 6479.6 | 6358.8 | 5714.4 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 66759.56 | 16584.7 | 16550.8 | 15823.7 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 123009.93 | - | - | - | |||||||||||||||||||||||
Total Investments | 11737.43 | 2883.8 | 2940.3 | 2533.7 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 35079.95 | 8625.8 | 8047.7 | 8567.7 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 18837.85 | 4843 | 3861.1 | 4181.5 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 280.54 | 1126.7 | 925 | 895 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 696.35 | 800.2 | 747.9 | 696.3 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -68.6 | 11.4 | -25.5 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 49.5 | -11.4 | 13 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | -800.57 | -162.1 | -843.9 | 294.8 | |||||||||||||||||||||
cash-flows.row.account-receivables | -587.98 | 59.6 | -1039.7 | -128.8 | |||||||||||||||||||||
cash-flows.row.inventory | -201.92 | -154.6 | -456.1 | 142.2 | |||||||||||||||||||||
cash-flows.row.account-payables | 0 | 1.5 | 645.4 | 306.9 | |||||||||||||||||||||
cash-flows.row.other-working-capital | -10.67 | -68.6 | 6.4 | -25.5 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 1553.85 | 662.1 | 440.7 | 499.1 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1730.18 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1379.1 | -1131.2 | -1256.4 | -1231.2 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | 16.29 | -15.8 | -40.1 | 29.8 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | -8385.3 | -7141.8 | -7267.4 | -10125.4 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 7625.57 | 7908.8 | 7749.1 | 9612.7 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | -161.49 | -176.4 | 24.4 | -46.2 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2275.27 | -556.5 | -790.4 | -1760.3 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -6196.07 | -7897.8 | -10279 | -11984.1 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | -4.6 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 4.6 | |||||||||||||||||||||
cash-flows.row.dividends-paid | -761.1 | -854.4 | -859.4 | -943.1 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | 5333.16 | 7382 | 10934.7 | 12687.6 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 734.91 | -1370.3 | -203.8 | -239.6 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 18.38 | 7.3 | 11.1 | -30.1 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | 191.84 | 488.4 | 286.5 | 342.8 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 12298.85 | 2991.3 | 2503 | 2216.5 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 12107.02 | 2503 | 2216.5 | 1873.7 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 1730.18 | 2407.9 | 1269.6 | 2372.7 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -1379.1 | -1131.2 | -1256.4 | -1231.2 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 351.08 | 1276.7 | 13.2 | 1141.6 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 11534.53 | 11594.6 | 13232.4 | 12359.2 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 7096.24 | 7059.5 | 7874.1 | 7605.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 4438.29 | 4535.1 | 5358.3 | 4753.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 412.1 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 432.26 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1317.3 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -30.25 | -34.1 | 921.7 | 784.4 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 3043.2 | 3032.2 | 3350 | 3130 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 10139.44 | 10091.7 | 11224.1 | 10735.6 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 86.54 | 85.2 | 88 | 80.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 345.8 | 343.7 | 434 | 461.7 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1317.3 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -30.25 | -34.1 | -1031.2 | -607.9 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -30.25 | -34.1 | 921.7 | 784.4 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -30.25 | -34.1 | -1031.2 | -607.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 345.8 | 343.7 | 434 | 461.7 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 671.4 | 891.2 | 800.2 | 747.9 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1510.64 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 839.23 | 926.5 | 2653.9 | 1893.9 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 808.99 | 892.4 | 1622.7 | 1286 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 212.47 | 215.5 | 496 | 361 | |||||||||||||||||||||||
income-statement-row.row.net-income | 280.54 | 302.1 | 1126.7 | 925 |
Preguntas frecuentes
Cuánto es Huapont Life Sciences Co., Ltd. (002004.SZ) activos totales?
Huapont Life Sciences Co., Ltd. (002004.SZ) los activos totales son 30727396560.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 5657008739.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.385.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 0.177.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.024.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.073.
¿Qué es Huapont Life Sciences Co., Ltd. (002004.SZ) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 302122026.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 8625844451.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 3032172071.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 4112423354.000.